SK279657B6 - Kryštalická forma (r)-3-metoxy-4-[1-metyl-5-(2-met - Google Patents

Kryštalická forma (r)-3-metoxy-4-[1-metyl-5-(2-met Download PDF

Info

Publication number
SK279657B6
SK279657B6 SK2670-92A SK267092A SK279657B6 SK 279657 B6 SK279657 B6 SK 279657B6 SK 267092 A SK267092 A SK 267092A SK 279657 B6 SK279657 B6 SK 279657B6
Authority
SK
Slovakia
Prior art keywords
methyl
ylmethyl
methoxy
indol
trifluorobutylcarbamoyl
Prior art date
Application number
SK2670-92A
Other languages
English (en)
Slovak (sk)
Other versions
SK267092A3 (en
Inventor
Murray W. Cuthbert
Original Assignee
Zeneca Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zeneca Limited filed Critical Zeneca Limited
Publication of SK267092A3 publication Critical patent/SK267092A3/sk
Publication of SK279657B6 publication Critical patent/SK279657B6/sk

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/10Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D209/20Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals substituted additionally by nitrogen atoms, e.g. tryptophane
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/10Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D209/24Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with an alkyl or cycloalkyl radical attached to the ring nitrogen atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/16Otologicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Plural Heterocyclic Compounds (AREA)
SK2670-92A 1991-09-05 1992-08-28 Kryštalická forma (r)-3-metoxy-4-[1-metyl-5-(2-met SK279657B6 (sk)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB919119001A GB9119001D0 (en) 1991-09-05 1991-09-05 Pharmaceutical agents

Publications (2)

Publication Number Publication Date
SK267092A3 SK267092A3 (en) 1999-02-11
SK279657B6 true SK279657B6 (sk) 1999-02-11

Family

ID=10700953

Family Applications (1)

Application Number Title Priority Date Filing Date
SK2670-92A SK279657B6 (sk) 1991-09-05 1992-08-28 Kryštalická forma (r)-3-metoxy-4-[1-metyl-5-(2-met

Country Status (21)

Country Link
US (2) US5352694A (cs)
EP (1) EP0531078B1 (cs)
JP (1) JP2914414B2 (cs)
KR (1) KR100254710B1 (cs)
AT (1) ATE138910T1 (cs)
AU (1) AU646587B2 (cs)
CA (1) CA2076722A1 (cs)
CZ (1) CZ281999B6 (cs)
DE (1) DE69211258T2 (cs)
DK (1) DK0531078T3 (cs)
FI (1) FI102372B (cs)
GB (2) GB9119001D0 (cs)
HK (1) HK18297A (cs)
HU (2) HU213410B (cs)
IL (1) IL102856A (cs)
NO (1) NO178370C (cs)
NZ (1) NZ244016A (cs)
RU (1) RU2095348C1 (cs)
SK (1) SK279657B6 (cs)
TW (1) TW302359B (cs)
ZA (1) ZA926374B (cs)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5958780A (en) * 1997-06-30 1999-09-28 Boston Advanced Technologies, Inc. Method for marking and identifying liquids
GB9726735D0 (en) * 1997-12-18 1998-02-18 Zeneca Ltd Pharmaceutical compositions
US6149914A (en) * 1999-07-12 2000-11-21 Patel; Jitendra Rambhai Asthma treatment
TWI353979B (en) * 2002-04-10 2011-12-11 Nippon Zoki Pharmaceutical Co Novel crystal form of 5-hydroxy-1-methylhydantoin
EP1765333A4 (en) 2004-07-14 2008-06-18 Inflammation Res Ct Company Lt PROCESS FOR INHIBITING TUMOR METASTASES

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4524152A (en) * 1982-12-30 1985-06-18 Pennwalt Corporation 1-Cyano-3-(fluoroalkyl)guanidines for lowering blood pressure
GB8623429D0 (en) * 1985-10-17 1986-11-05 Ici America Inc Carboximide derivatives
MY103259A (en) * 1987-04-15 1993-05-29 Ici America Inc Aliphatic carboxamides
GB8906032D0 (en) * 1988-04-14 1989-04-26 Ici America Inc Hetera-aliphatic carboxamides
GB8927981D0 (en) * 1989-12-11 1990-02-14 Ici Plc Carbamoyl derivative
GB9026427D0 (en) * 1990-12-05 1991-01-23 Ici Plc Chemical process
GB9026425D0 (en) * 1990-12-05 1991-01-23 Ici Plc Process
GB9027018D0 (en) * 1990-12-12 1991-01-30 Ici Plc Heterocyclic compounds
IL100091A (en) * 1990-12-12 1998-08-16 Zeneca Ltd Pharmaceutical compositions containing a physical form of n-[4-[5-(cyclopentyloxycarbonyl)amino-1-methyl indol-3-yl-methyl]-2-methylbenzenesulpho-namide and process for their preparation

Also Published As

Publication number Publication date
TW302359B (cs) 1997-04-11
JP2914414B2 (ja) 1999-06-28
AU646587B2 (en) 1994-02-24
GB9119001D0 (en) 1991-10-23
SK267092A3 (en) 1999-02-11
NO178370B (no) 1995-12-04
HU213410B (en) 1997-06-30
RU2095348C1 (ru) 1997-11-10
KR100254710B1 (ko) 2000-05-01
ZA926374B (en) 1993-03-05
EP0531078A1 (en) 1993-03-10
KR930005976A (ko) 1993-04-20
IL102856A0 (en) 1993-01-31
DE69211258T2 (de) 1996-10-02
HU9202660D0 (en) 1992-10-28
IL102856A (en) 1996-12-05
GB9216774D0 (en) 1992-09-23
CZ267092A3 (en) 1993-03-17
HU210879A9 (en) 1995-09-28
CA2076722A1 (en) 1993-03-06
US5466826A (en) 1995-11-14
FI102372B1 (fi) 1998-11-30
FI923869L (fi) 1993-03-06
DK0531078T3 (da) 1996-10-14
ATE138910T1 (de) 1996-06-15
NO178370C (no) 1996-03-13
NO923467D0 (no) 1992-09-04
NO923467L (no) 1993-03-08
HK18297A (en) 1997-02-13
US5352694A (en) 1994-10-04
NZ244016A (en) 1995-01-27
AU2101292A (en) 1993-03-11
EP0531078B1 (en) 1996-06-05
JPH05194385A (ja) 1993-08-03
FI102372B (fi) 1998-11-30
CZ281999B6 (cs) 1997-04-16
HUT69696A (en) 1995-09-28
FI923869A0 (fi) 1992-08-28
DE69211258D1 (de) 1996-07-11

Similar Documents

Publication Publication Date Title
EP3765439B1 (en) Novel calcium salt polymorphs as anti-inflammatory, immunomodulatory and anti-proliferatory agents
SK279814B6 (sk) Spôsob prípravy n-[4-[5-(cyklopentyloxykarbonyl)am
EP1919893A2 (en) Polymorphic forms of imatinib mesylate and processes for their preparation as well as of amorphous imatinib mesylate and form alpha
AU1641592A (en) Crystalline tiagabine hydrochloride monohydrate, its preparation and use
JP2003528100A (ja) カベルゴリンの結晶性形態iを調製するための方法
SK279657B6 (sk) Kryštalická forma (r)-3-metoxy-4-[1-metyl-5-(2-met
TW201827436A (zh) 一種jak激酶抑制劑的硫酸氫鹽的晶型及其製備方法
JPH09291076A (ja) 置換グアニジン誘導体およびその製法
JPS62145080A (ja) N−(ピロ−ル−1−イル)ピリジンアミン類およびそれらの製造方法
WO2015037010A1 (en) Preparation of vilazodone hydrochloride crystalline form iv
US20070032506A1 (en) Crystalline forms of (2r-trans)-6-chloro-5[[4-[(4-fluorophenyl)methyl]-2,5-dimethyl-1-piperazinyl]carbonyl]-n,n, 1-trimethyl-alpha-oxo-1h-indole-3-acetamide monohydrochloride
US20040058901A1 (en) Crystalline ethanolate solvate form of zafirluskast process for manufacture and pharmaceutical compositions thereof
US20040038985A1 (en) Crystal forms of 1- [6-chloro-5-(trifluoromethly) -2-pyridinyl] piperazine hydrochloride
EP4214195A1 (en) Solid state forms of gefapixant and process for preparation thereof
EP2389360A2 (en) A process for the preparation of zofenopril and its pharmaceutically acceptable salts thereof
HK40035594A (en) Novel calcium salt polymorphs as anti-inflammatory, immunomodulatory and anti-proliferatory agents
HK40035594B (en) Novel calcium salt polymorphs as anti-inflammatory, immunomodulatory and anti-proliferatory agents
HK1259825B (en) Synthesis of indazoles
HK1259825A1 (en) Synthesis of indazoles